Canaccord Lifts PT on Biodesix (BDSX) on Raised Revenue Assumptions
Biodesix, Inc. (NASDAQ:BDSX) is one of the best oversold growth stocks to invest in now. Canaccord lifted the price target on Biodesix, Inc.
Biodesix Inc (BDSX)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | AIGH Investment Partners Orin Hirschman | 758,328 | $10,995,756 | 1.5% | |
| 2. | Soleus Capital Guy Levy | 416,599 | $6,040,686 | 0.24% | |
| 3. | Birchview Capital Matthew Strobeck | 286,804 | $4,158,657 | 2.37% | |
| 4. | Opaleye Management James A. Silverman | 238,047 | $3,451,682 | 0.45% | |
| 5. | Marshall Wace LLP Paul Marshall And Ian Wace | 141,636 | $2,053,724 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $11.80 | 20,000 | $236,064.00 | 1,563,210 | 2026-01-26 | Filing | |
| $11.81 | 80,000 | $944,672.00 | 1,543,210 | 2026-01-23 | Filing | |
| $10.96 | 82,465 | $903,560.76 | 1,463,210 | 2026-01-22 | Filing | |
| $7.04 | 142,045 | $999,996.80 | 1,380,745 | 2025-09-19 | Filing | |
| $6.17 | 3,056 | $18,853.99 | 1,238,700 | 2025-09-18 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $12.78 | 556 | $7,103.23 | 10,359 | 2026-02-23 | Filing | |
| $12.78 | 535 | $6,834.95 | 9,819 | 2026-02-23 | Filing | |
| $12.78 | 535 | $6,834.95 | 16,231 | 2026-02-23 | Filing | |
| $12.78 | 211 | $2,695.65 | 1,586 | 2026-02-23 | Filing | |
| $12.78 | 1,490 | $19,035.64 | 48,767 | 2026-02-23 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 489,824 | $7,102,448 | 0.66% | |
| 2. | 458,438 | $6,647,351 | 0.01% | |
| 3. | 255,161 | $3,699,835 | 0% | |
| 4. | 132,086 | $1,915,247 | 0.3% | |
| 5. | 49,998 | $725,594 | 0% |
News See All
10 Oversold Growth Stocks to Invest In Now
On May 18, Jeffrey Solomon, vice chair and special advisor at TD Bank U.S., appeared on CNBC’s ‘Squawk on the Street’ to talk about how the Iran war and energy prices are driving markets, his economic...
Biodesix, Inc. (NASDAQ:BDSX) Q1 2026 Earnings Call Transcript
Operator: Name is Tina, and I will be your conference operator today. At this time, I would like to welcome everyone to the Biodesix, Inc. First Quarter 2026 Earnings Conference Call.
Biodesix, Inc. (NASDAQ:BDSX) Q4 2025 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Biodesix, Inc. Fourth Quarter 2025 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Biodesix, Inc. (NASDAQ:BDSX) Q3 2025 Earnings Call Transcript
Christopher Brinzey: Thank you, operator, and good afternoon, everyone. Today, Biodesix released results from the third quarter of 2025.
Biodesix, Inc. (NASDAQ:BDSX) Q2 2025 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Biodesix Q2 2025 Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded.
Biodesix, APAPP Partner to Launch First CME-Accredited Education Program for Lung Cancer Biomarkers
Biodesix Inc. (NASDAQ:BDSX) is one of the best penny stocks under $1 to buy now. On June 10, Biodesix announced a new partnership with the Association of Pulmonary Advanced Practice Providers/APAPP.
12 Best Penny Stocks Under $1 to Buy Now
On July 18, Greg Tuorto of Goldman Sachs joined CNBC's 'Closing Bell' to state that the small-cap market is starting to show signs of life.
Biodesix, Inc. (NASDAQ:BDSX) Q1 2025 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the Biodesix's Q1 2025 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Biodesix, Inc. (NASDAQ:BDSX) Q4 2024 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Biodesix, Inc. Q4 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Hedge Fund Resource Center